BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8207229)

  • 1. Quantitative differences in cell surface expression of class I MHC antigens on murine epidermal Langerhans cells.
    Sharrow SO; Barden LA; Singer A; Katz SI
    J Immunol; 1994 Jul; 153(1):110-6. PubMed ID: 8207229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. II. Levels of expression of H-2K, H-2D, and H-2L in different mouse strains.
    Dower SK; Segal DM
    J Immunol; 1985 Jan; 134(1):431-5. PubMed ID: 2578048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex.
    Caughman SW; Sharrow SO; Shimada S; Stephany D; Mizuochi T; Rosenberg AS; Katz SI; Singer A
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7438-42. PubMed ID: 3532113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells.
    MacAry PA; Lindsay M; Scott MA; Craig JI; Luzio JP; Lehner PJ
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3982-7. PubMed ID: 11274420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of MHC incompatible, Langerhans cell-free epidermal keratinocyte allografts in the rat.
    Yeoman H; Munro AJ; Stanley MA
    Reg Immunol; 1990; 3(2):75-81. PubMed ID: 2088475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonclassical MHC-I and Japanese encephalitis virus infection: induction of H-2Q4, H-2T23 and H-2T10.
    Abraham S; Yaddanapudi K; Thomas S; Damodaran A; Ramireddy B; Manjunath R
    Virus Res; 2008 May; 133(2):239-49. PubMed ID: 18314211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Langerhans cells and presentation of antigens].
    Hanau D; Esposito-Farese ME; de la Salle H
    Pathol Biol (Paris); 1992 Feb; 40(2):109-13. PubMed ID: 1608651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femtosecond two-photon high-resolution 3D imaging, spatial-volume rendering and microspectral characterization of immunolocalized MHC-II and mLangerin/CD207 antigens in the mouse epidermis.
    Tirlapur UK; Mulholland WJ; Bellhouse BJ; Kendall M; Cornhill JF; Cui Z
    Microsc Res Tech; 2006 Oct; 69(10):767-75. PubMed ID: 16941665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells.
    Hamrah P; Zhang Q; Liu Y; Dana MR
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):639-46. PubMed ID: 11867578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recycling class I MHC antigens: dynamics of internalization, acidification, and ligand-degradation in murine T lymphoblasts.
    Tse DB; Cantor CR; McDowell J; Pernis B
    J Mol Cell Immunol; 1986; 2(6):315-29. PubMed ID: 3509917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Most gamma delta T cells develop normally in the absence of MHC class II molecules.
    Bigby M; Markowitz JS; Bleicher PA; Grusby MJ; Simha S; Siebrecht M; Wagner M; Nagler-Anderson C; Glimcher LH
    J Immunol; 1993 Nov; 151(9):4465-75. PubMed ID: 8409413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha.
    Yeoman H; Anderton JG; Stanley MA
    Immunology; 1989 Jan; 66(1):100-5. PubMed ID: 15493270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
    Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
    J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for transforming growth factor-beta1 in maintaining the differentiated state of Langerhans cells in human epidermis.
    Pieri L; Domenici L; Romagnoli P
    Ital J Anat Embryol; 2006; 111(3):133-49. PubMed ID: 17312920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunocytochemical study of MHC class I expression on human Langerhans cells and melanocytes.
    Moseley RP; Brown JI; Auld J; Mumtaz H; Rainey AJ; Kirkham N; Gelsthorpe K; Masters R; Smith ME
    J Pathol; 1997 Apr; 181(4):419-25. PubMed ID: 9196440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
    Serreze DV; Gaskins HR; Leiter EH
    J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.